This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Lupus Foundation Of America Recognizes Top Researchers With Prestigious Evelyn V. Hess Award And Mary Betty Stevens Prize

The 2012  Mary Betty Stevens, M.D., Young Investigator Prize is awarded annually in recognition of exceptional achievements of an investigator in the early part of his or her career in lupus research, and as a tribute to Dr. Stevens' significant contributions to the field.

Dr. Kamen, this year's recipient, is a devoted researcher and clinician who has focused her career to date on understanding the natural history of autoimmune diseases, in particular lupus. She serves as the Clinical Director for the Lupus Clinical Trials Consortium at MUSC, is Chair of the Southern Section American Federation for Medical Research, and is a member of the Lupus Foundation of America's Medical-Scientific Advisory Council.

On the international level, Dr. Kamen is a member of the Systemic Lupus International Collaborating Clinics (SLICC). Her future interests include furthering the understanding of the pathogenic mechanisms responsible for lupus while working to improve  the quality of life for people living with this disease.

The LFA is the foremost national nonprofit health organization dedicated to finding the causes of and cure for lupus and providing support, services, and hope to all people affected by lupus. More information about lupus and our ongoing research efforts is available by visiting   www.lupus.org .

SOURCE Lupus Foundation of America

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,319.71 +128.34 0.75%
S&P 500 2,012.10 +9.94 0.50%
NASDAQ 4,654.2210 +16.2270 0.35%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs